Stock A271980 JEIL PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Jeil Pharmaceutical Co.,Ltd

Equities

A271980

KR7271980005

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
17,170 KRW +0.06% Intraday chart for Jeil Pharmaceutical Co.,Ltd -1.55% +0.41%
2023 Jeil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020. CI

Business Summary

JEIL PHARMACEUTICAL CO.,LTD is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company provides anti-inflammatory painkillers, anticancer drugs, gastritis drugs, antibiotics, ulcer treatments, antidepressant drugs, pollakisuria and incontinence treatments, impetigo drugs, septicemia treatments, hyperlipidemia treatments, peripheral neuropathic pain drugs, hypertension drugs and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 964

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
97.1 %
722,230 100.0 % 705,338 97.1 % -2.34%
Research and Development
2.9 %
0 0.0 % 21,056 2.9 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
722,230 100.0 % 726,394 100.0 % +0.58%

Managers

Managers TitleAgeSince
Seok-Jae Sung CEO
 Chief Executive Officer 63 -
Chang-Seok Lee CTO
 Chief Tech/Sci/R&D Officer 64 -
Chi-Guk No BRD
 Director/Board Member 52 -
Sang-Cheol Han BRD
 Director/Board Member 48 -
Dong-Soo Yang SAM
 Sales & Marketing 51 -

Members of the board

Members of the board TitleAgeSince
Sang-Cheol Han BRD
 Director/Board Member 48 -
Seok-Jae Sung CEO
 Chief Executive Officer 63 -
Chi-Guk No BRD
 Director/Board Member 52 -
Oh-Sik Kim BRD
 Director/Board Member 67 -
Ho-Sang Jeong BRD
 Director/Board Member 48 -
Byeong-Do Jang BRD
 Director/Board Member 49 -
Chang-Seok Lee CTO
 Chief Tech/Sci/R&D Officer 64 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,704,872 5,415,037 ( 36.82 %) 133,355 ( 0.9069 %) 36.82 %

Shareholders

NameEquities%Valuation
JEIL PHARMACEUTICAL CO.,LTD
0.8695 %
127,861 0.8695 % 2 M ₩
Dimensional Fund Advisors Ltd.
0.0113 %
1,660 0.0113 % 19 986 ₩
DFA Australia Ltd.
0.004019 %
591 0.004019 % 7 115 ₩
Mirae Asset Global Investments Co., Ltd.
0.002380 %
350 0.002380 % 4 214 ₩
Korea Investment Management Co., Ltd.
0.000000 %
0 0.000000 % - ₩

Holdings

NameEquities%Valuation
JEIL PHARMACEUTICAL CO.,LTD
0.87%
 127,861 0.87% 1,539,402 $

Company contact information

Jeil Pharmaceutical Co., Ltd.

343 Sapyeong-daero Seocho-gu

06543, Seoul

+

http://www.jeilpharm.co.kr
address Jeil Pharmaceutical Co.,Ltd(A271980)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
JEIL PHARMACEUTICAL CO.,LTD Stock Jeil Pharmaceutical Co.,Ltd
+0.41% 185M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.98% 43.92B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.33% 23.09B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.25% 15.35B
CIPLA LIMITED Stock Cipla Limited
+14.03% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+46.40% 12.02B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.98% 7B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.88% 5.6B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A271980 Stock
  4. Company Jeil Pharmaceutical Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW